Suchergebnisse - "He, Yingjian"

PubPharm (67)

1

An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer : Modeling and external validation

enthalten in: Cancer | 2024

von Zheng, Q. | Yan, H. | He, Y. | +7

2

Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer : exploratory analysis of data from the CLEOPATRA trial

enthalten in: Breast cancer research : BCR | 2024

von Ding, N. | Pang, J. | Liu, X. | +11

3

Author Correction : Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial

enthalten in: NPJ breast cancer | 2023

von Yang, Y. | He, Y. | Fan, Z. | +20

ErratumFor: NPJ Breast Cancer. 2023 Jun 21;9(1):54. - PMID 37344451

4

Observation Effectiveness of Dose-Dense Neoadjuvant Anthracycline Sequential Weekly Paclitaxel for Triple-Negative Breast Cancer Patients

enthalten in: Clinical breast cancer | 2023

von Wang, X. | Wang, J. | He, Y. | +4

5

Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized clinical trial

enthalten in: ResearchSquare.com | 2023

von Ouyang, T. | Yang, Y. | He, Y. | +20

6

Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy : a randomized trial

enthalten in: NPJ breast cancer | 2023

von Yang, Y. | He, Y. | Fan, Z. | +20

ErratumIn: NPJ Breast Cancer. 2023 Jul 24;9(1):62. - PMID 37488099

7

Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer : results of a prospective multi-center study

enthalten in: Breast cancer research and treatment | 2022

von Wang, X. | Fan, Z. | Wang, X. | +17

8

Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study

enthalten in: Breast cancer research and treatment | 2022

von Wang, X. | Fan, Z. | Wang, X. | +17

9

Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study

enthalten in: Breast cancer research and treatment | 2022

von Wang, X. | Fan, Z. | Wang, X. | +17

10

A phase III study of HR-positive/HER2-negative and lymph node-positive breast cancer non- responsive to primary chemotherapy: a randomized clinical trial

enthalten in: ResearchSquare.com | 2022

von Yang, Y. | He, Y. | Fan, Z. | +20

1
2
3
4
5
6
7
Nächster »
[7]